Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects

1. De Lago, E.
2. Moreno-Martet, M.
3. Cabranes, A.
4. Ramos, J.A.
5. Fernández-Ruiz, J.